DrugPatentWatch Database Preview
Investigational Drug Information for Oteracil
Email this page to a colleague
What is the development status for investigational drug Oteracil?
Oteracil is an investigational drug.
There have been 80 clinical trials for Oteracil.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2016.
The most common disease conditions in clinical trials are Stomach Neoplasms, Pancreatic Neoplasms, and Adenocarcinoma. The leading clinical trial sponsors are Fudan University, Taiho Oncology, Inc., and Yonsei University.
There are four hundred and thirty-six US patents protecting this investigational drug and four international patents.
Summary for Oteracil
| US Patents | 436 |
| International Patents | 4,617 |
| US Patent Applications | 932 |
| WIPO Patent Applications | 894 |
| Japanese Patent Applications | 588 |
| Clinical Trial Progress | Phase 3 (2016-09-01) |
| Vendors | 28 |
Recent Clinical Trials for Oteracil
| Title | Sponsor | Phase |
|---|---|---|
| Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Phase 2/Phase 3 |
| A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Canc | Ono Pharmaceutical Co. Ltd | Phase 3 |
| HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction | Xuefei.Wang | Phase 2 |
Clinical Trial Summary for Oteracil
Top disease conditions for Oteracil
Top clinical trial sponsors for Oteracil
US Patents for Oteracil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Oteracil | ⤷ Sign up for a Free Trial | Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP) | BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE) | ⤷ Sign up for a Free Trial |
| Oteracil | ⤷ Sign up for a Free Trial | Aryl-cyanoguanidine compounds | Bayer Pharma Aktiengesellschaft (Berlin, DE) | ⤷ Sign up for a Free Trial |
| Oteracil | ⤷ Sign up for a Free Trial | Metal-salen complex compound, local anesthetic and antineoplastic drug | IHI Corporation (Tokyo, JP) Ishikawa; Yoshihiro (Tokyo, JP) | ⤷ Sign up for a Free Trial |
| Oteracil | ⤷ Sign up for a Free Trial | Multimodal silica-based nanoparticles | ⤷ Sign up for a Free Trial | |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Oteracil
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Oteracil | Argentina | AR098961 | 2033-12-23 | ⤷ Sign up for a Free Trial |
| Oteracil | Australia | AU2014372833 | 2033-12-23 | ⤷ Sign up for a Free Trial |
| Oteracil | Canada | CA2934617 | 2033-12-23 | ⤷ Sign up for a Free Trial |
| Oteracil | China | CN106163568 | 2033-12-23 | ⤷ Sign up for a Free Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
